Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Journal of Rheumatology Publishes Manuscript on Scientific Study of Celadrin™, a Natural-Based Product for Joint Function and Mobility
- Journal of Rheumatology Publishes Manuscript on Scientific Study of Celadrin™, a Natural-Based Product for Joint Function and Mobility
- New Research Shows Mineral Supplement SierraSil(TM) and Vincaria® Cat’s Claw Suppress Cartilage Degradation
Findings are published in the current edition of the Journal of the American Nutraceutical Association (JANA).
- New Research Shows Mineral Supplement SierraSil(TM) and Vincaria® Cat’s Claw Suppress Cartilage Degradation
Findings are published in the current edition of the Journal of the American Nutraceutical Association (JANA).
- New Research Shows Mineral Supplement SierraSil(TM) and Vincaria® Cat’s Claw Suppress Cartilage Degradation
Findings are published in the current edition of the Journal of the American Nutraceutical Association (JANA).
- Christmas Tree Bark May Fight Arthritis
Extract of scotch pine bark shows anti-inflammatory effect in preliminary study.
- Christmas Tree Bark May Fight Arthritis
Extract of scotch pine bark shows anti-inflammatory effect in preliminary study.
- Christmas Tree Bark May Fight Arthritis
Extract of scotch pine bark shows anti-inflammatory effect in preliminary study.
- Two Seminal Studies Demonstrate Benefit of Glucosamine And Chondroitin In Osteoarthritis Patients
National Institutes of Health (NIH) trial shows effectiveness of glucosamine/chondroitin combination for moderate to severe pain, while multi-center European study favorably compares glucosamine to over-the-counter remedy for joint pain.
- Two Seminal Studies Demonstrate Benefit of Glucosamine And Chondroitin In Osteoarthritis Patients
National Institutes of Health (NIH) trial shows effectiveness of glucosamine/chondroitin combination for moderate to severe pain, while multi-center European study favorably compares glucosamine to over-the-counter remedy for joint pain.
- Two Seminal Studies Demonstrate Benefit of Glucosamine And Chondroitin In Osteoarthritis Patients
National Institutes of Health (NIH) trial shows effectiveness of glucosamine/chondroitin combination for moderate to severe pain, while multi-center European study favorably compares glucosamine to over-the-counter remedy for joint pain.
- Phytochemicals May Protect Cartilage, Prevent Pain in Joints
Johns Hopkins researchers, in a study published in the Proceedings of the National Academy of Sciences, have determined that certain phytochemicals found in cruciferous plants, including broccoli, boost the activity of helpful phase 2 enzymes which in turn, help protect tisue and prevent inflammation. The cell study involved adding thse inducers to a dish containing chondrocyte cells that are crucial to maintaining healthy joints, with the inducers apparently preventing the activation of the inflammatory COX-2 enzyme.
- Phytochemicals May Protect Cartilage, Prevent Pain in Joints
Johns Hopkins researchers, in a study published in the Proceedings of the National Academy of Sciences, have determined that certain phytochemicals found in cruciferous plants, including broccoli, boost the activity of helpful phase 2 enzymes which in turn, help protect tisue and prevent inflammation. The cell study involved adding thse inducers to a dish containing chondrocyte cells that are crucial to maintaining healthy joints, with the inducers apparently preventing the activation of the inflammatory COX-2 enzyme.
- Phytochemicals May Protect Cartilage, Prevent Pain in Joints
Johns Hopkins researchers, in a study published in the Proceedings of the National Academy of Sciences, have determined that certain phytochemicals found in cruciferous plants, including broccoli, boost the activity of helpful phase 2 enzymes which in turn, help protect tisue and prevent inflammation. The cell study involved adding thse inducers to a dish containing chondrocyte cells that are crucial to maintaining healthy joints, with the inducers apparently preventing the activation of the inflammatory COX-2 enzyme.
- New Clinical Trial Demonstrates Effectiveness of SierraSil®, Nutraceutical Mineral Complex for Osteoarthritis
Results of double-blind, randomized, placebo-controlled, multi-centered clinical trial, published in the Journal of Inflammation, indicate that SierraSil provided significant symptomatic relief after one week, to patients with osteoarthritis of the knee.
- New Clinical Trial Demonstrates Effectiveness of SierraSil®, Nutraceutical Mineral Complex for Osteoarthritis
Results of double-blind, randomized, placebo-controlled, multi-centered clinical trial, published in the Journal of Inflammation, indicate that SierraSil provided significant symptomatic relief after one week, to patients with osteoarthritis of the knee.
- New Clinical Trial Demonstrates Effectiveness of SierraSil®, Nutraceutical Mineral Complex for Osteoarthritis
Results of double-blind, randomized, placebo-controlled, multi-centered clinical trial, published in the Journal of Inflammation, indicate that SierraSil provided significant symptomatic relief after one week, to patients with osteoarthritis of the knee.
- New Clinical Trial Demonstrates Effectiveness of SierraSil®, Nutraceutical Mineral Complex for Osteoarthritis
Results of double-blind, randomized, placebo-controlled, multi-centered clinical trial, published in the Journal of Inflammation, indicate that SierraSil provided significant symptomatic relief after one week, to patients with osteoarthritis of the knee.
- New Clinical Trial Demonstrates Effectiveness of SierraSil®, Nutraceutical Mineral Complex for Osteoarthritis
Results of double-blind, randomized, placebo-controlled, multi-centered clinical trial, published in the Journal of Inflammation, indicate that SierraSil provided significant symptomatic relief after one week, to patients with osteoarthritis of the knee.
- NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health
Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis".
- NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health
Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis".
- NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health
Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis".
- NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health
Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis".
- NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health
Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis".
- NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health
Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis".
- NIH-Sponsored Trial Shows Supplements Relieve Arthritis Pain
Council for Responsible Nutrition comments on recently released clinical trial results of glucosamine and chondroitin and pain relief from osteoarthritis.
- NIH-Sponsored Trial Shows Supplements Relieve Arthritis Pain
Council for Responsible Nutrition comments on recently released clinical trial results of glucosamine and chondroitin and pain relief from osteoarthritis.
- NIH-Sponsored Trial Shows Supplements Relieve Arthritis Pain
Council for Responsible Nutrition comments on recently released clinical trial results of glucosamine and chondroitin and pain relief from osteoarthritis.
- NIH-Sponsored Trial Shows Supplements Relieve Arthritis Pain
Council for Responsible Nutrition comments on recently released clinical trial results of glucosamine and chondroitin and pain relief from osteoarthritis.
- NIH-Sponsored Trial Shows Supplements Relieve Arthritis Pain
Council for Responsible Nutrition comments on recently released clinical trial results of glucosamine and chondroitin and pain relief from osteoarthritis.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Study Shows Supplements Relieve Osteoarthritis Pain
A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain.
- Study Shows Supplements Relieve Osteoarthritis Pain
A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain.
- Study Shows Supplements Relieve Osteoarthritis Pain
A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain.
- Study Shows Supplements Relieve Osteoarthritis Pain
A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain.
- Study Shows Supplements Relieve Osteoarthritis Pain
A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain.
- Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain
Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements.
- Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain
Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements.
- Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain
Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements.
- Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain
Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements.
- Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain
Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements.
- Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain
Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements.
- NEJM Study Shows Supplements Relieve Mild Forms of Arthritis
NNFA comments on NIH GAIT study concluding that glucosamine and chondroitin are effective in helping people who suffer the most from osteoarthritis, those who experience moderate to extreme pain.
- NEJM Study Shows Supplements Relieve Mild Forms of Arthritis
NNFA comments on NIH GAIT study concluding that glucosamine and chondroitin are effective in helping people who suffer the most from osteoarthritis, those who experience moderate to extreme pain.
- NEJM Study Shows Supplements Relieve Mild Forms of Arthritis
NNFA comments on NIH GAIT study concluding that glucosamine and chondroitin are effective in helping people who suffer the most from osteoarthritis, those who experience moderate to extreme pain.
- New Study To Evaluate Celadrin Capsules For Patients With Knee Pain
Company announces that a new 60-day, double-blind, placebo-controlled multi-site study has been commissioned on Celadrin®, by its developer Imagenetix, Inc. on patients diagnosed with moderate to severe knee pain
- New Study To Evaluate Celadrin Capsules For Patients With Knee Pain
Company announces that a new 60-day, double-blind, placebo-controlled multi-site study has been commissioned on Celadrin®, by its developer Imagenetix, Inc. on patients diagnosed with moderate to severe knee pain
- New Study To Evaluate Celadrin Capsules For Patients With Knee Pain
Company announces that a new 60-day, double-blind, placebo-controlled multi-site study has been commissioned on Celadrin®, by its developer Imagenetix, Inc. on patients diagnosed with moderate to severe knee pain
- Research Breakthrough in Arthritis: Natural Product Activates Gene to Regenerate Human Cartilage
Scientists at Case Western Reserve University and Albany Medical College have determined a natural product combination, Reparagen, has been shown to activate a critical repair gene, IGF-1, in human cartilage while blocking joint destruction associated with inflammation.
- Research Breakthrough in Arthritis: Natural Product Activates Gene to Regenerate Human Cartilage
Scientists at Case Western Reserve University and Albany Medical College have determined a natural product combination, Reparagen, has been shown to activate a critical repair gene, IGF-1, in human cartilage while blocking joint destruction associated with inflammation.
- Research Breakthrough in Arthritis: Natural Product Activates Gene to Regenerate Human Cartilage
Scientists at Case Western Reserve University and Albany Medical College have determined a natural product combination, Reparagen, has been shown to activate a critical repair gene, IGF-1, in human cartilage while blocking joint destruction associated with inflammation.
- Research Breakthrough in Arthritis: Natural Product Activates Gene to Regenerate Human Cartilage
Scientists at Case Western Reserve University and Albany Medical College have determined a natural product combination, Reparagen, has been shown to activate a critical repair gene, IGF-1, in human cartilage while blocking joint destruction associated with inflammation.
- Research Breakthrough in Arthritis: Natural Product Activates Gene to Regenerate Human Cartilage
Scientists at Case Western Reserve University and Albany Medical College have determined a natural product combination, Reparagen, has been shown to activate a critical repair gene, IGF-1, in human cartilage while blocking joint destruction associated with inflammation.
- Research Breakthrough in Arthritis: Natural Product Activates Gene to Regenerate Human Cartilage
Scientists at Case Western Reserve University and Albany Medical College have determined a natural product combination, Reparagen, has been shown to activate a critical repair gene, IGF-1, in human cartilage while blocking joint destruction associated with inflammation.
- Research Breakthrough in Arthritis: Natural Product Activates Gene to Regenerate Human Cartilage
Scientists at Case Western Reserve University and Albany Medical College have determined a natural product combination, Reparagen, has been shown to activate a critical repair gene, IGF-1, in human cartilage while blocking joint destruction associated with inflammation.
- Research Breakthrough in Arthritis: Natural Product Activates Gene to Regenerate Human Cartilage
Scientists at Case Western Reserve University and Albany Medical College have determined a natural product combination, Reparagen, has been shown to activate a critical repair gene, IGF-1, in human cartilage while blocking joint destruction associated with inflammation.
- Research Breakthrough in Arthritis: Natural Product Activates Gene to Regenerate Human Cartilage
Scientists at Case Western Reserve University and Albany Medical College have determined a natural product combination, Reparagen, has been shown to activate a critical repair gene, IGF-1, in human cartilage while blocking joint destruction associated with inflammation.
- Arthritis Breakthrough that Activates the Gene Responsible for Regenerating Cartilage Enters Clinical Trials
The clinical study being conducted by clinical research organization Santerra Pharmaceuticals, LLC was submitted to Current Controlled Trials for review of the protocol and assignment of an International Standardized Randomized Controlled Trial Number (ISRCTN25438351).
- Arthritis Breakthrough that Activates the Gene Responsible for Regenerating Cartilage Enters Clinical Trials
The clinical study being conducted by clinical research organization Santerra Pharmaceuticals, LLC was submitted to Current Controlled Trials for review of the protocol and assignment of an International Standardized Randomized Controlled Trial Number (ISRCTN25438351).
- Arthritis Breakthrough that Activates the Gene Responsible for Regenerating Cartilage Enters Clinical Trials
The clinical study being conducted by clinical research organization Santerra Pharmaceuticals, LLC was submitted to Current Controlled Trials for review of the protocol and assignment of an International Standardized Randomized Controlled Trial Number (ISRCTN25438351).
- Arthritis Breakthrough that Activates the Gene Responsible for Regenerating Cartilage Enters Clinical Trials
The clinical study being conducted by clinical research organization Santerra Pharmaceuticals, LLC was submitted to Current Controlled Trials for review of the protocol and assignment of an International Standardized Randomized Controlled Trial Number (ISRCTN25438351).
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Lincoln, New Zealand, November 9, 2005 - Recent laboratory research suggests that the new keratin joint ingredient Cynatine FLX activates two important joint antioxidant defense enzymes and stimulates the regeneration of cells.
The findings, released today by Keratec, support the wool-extracted ingredient's innovative four-fold mechanism that:
· helps to prevent joint breakdown and build joint resilience
· has an anti-inflammatory effect
· increases the key antioxidant glutathione and
· provides direct antioxidant protection for cells.
Independent tests on rats demonstrated that orally ingested Cynatine FLX activated two important joint antioxidant defense enzymes, glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD). Cynatine FLX increased the levels of GSH-PX, an important joint antioxidant enzyme that needs glutathione to work and is activated in healthy joints. Cynatine FLX also increased the levels of superoxide dismutase (SOD), another joint antioxidant defense enzyme, which is reduced in damaged joints. This enzyme activation means that Cynatine FLX is not only a strong antioxidant itself, but that it also activates the body's cellular antioxidant machinery to fight damage to joints. The same set of tests indicated that Cynatine supports the body's natural antioxidant processes, shown by reductions in malondialdehde (MDA), a proven biological marker of oxidative stress. In a separate trial, laboratory testing with human and bovine cells demonstrated that Cynatine FLX stimulated cell growth up to 50 percent faster than control samples.
Potential Implications for Joint Health
Taken together, the data supports the case for the four-fold action of Cynatine FLX in helping damaged joints, which frequently suffer from a four-pronged attack. First, shock-absorbing cartilage and other polymers break down and the joint cells lose their ability to make new polymers. Free radicals generated by inflammation cause further damage. Third, the cells of the joint, which normally produce anti-inflammatory molecules like taurine, lose this ability to fight free radicals and finally, glutathione, the body's master antioxidant for fighting free radicals, decreases. Fighting any one of these individual attacks (for example, using glucosamine to build new joint polymers or using antioxidants to fight free radicals) is proven to help joints recover.
Keratec CEO Bruce Foulds said the promising early results lend support to Cynatine FLX's innovative four-fold joint mechanism that addresses a range of joint processes with multiple actions, compared with single-action ingredients on the market.
"We have an ambitious research program in place. We are very excited at the potential of this highly-differentiated product in a market that is becoming increasingly commoditized. We will continue to research and evaluate the efficacy of this ingredient," he said. Keratec and its research partners are further investigating the role of Cynatine FLX in building joint cartilage and supporting the anti-inflammatory response. Full clinical trials are being developed.
About Keratin and Cynatine FLX
Derived from pure New Zealand wool, Cynatine FLX is the world's first intact digestible keratin extract. Keratin, nature's richest protein sulfur source, is the polymer-forming protein of which wool, hair and skin are made. Keratin has the potential to improve parts of the body that require polymers to work, such as joints, which use polymers to absorb shock and keep the joint together.
Traditional keratin-extraction processes dissolve and inactivate the protein's constituent amino acids. Keratec's patent-pending extraction process makes it possible for the first time to leave the natural amino acid structure of keratin intact and therefore fully potent. These pure keratin amino acids are potentially available to the body to support its own joint maintenance and resilience processes.
Cynatine FLX is non-allergenic and, unlike other keratins that need to be dissolved before they can be digested, requires no undesirable stabilizers such as sulphate or hydrochloric acid.
About the Researchers
Cynatine FLX is the culmination of more than 40 years of research into wool properties, keratin ultra-structure and protein chemistry by Keratec and its research partners, which include Canesis Network, the Wellington School of Medicine at the University of Otago (New Zealand), AgResearch New Zealand and YiLing Pharmaceuticals, a large company in the emerging Chinese pharmaceutical industry.
About Keratec (www.keratec.co.nz)
Keratec is a New Zealand-based biotechnology company producing new materials from natural sources using patent-pending technologies. Its core technologies involve the extraction and purification of intact fractions of natural keratin proteins and lipids from wool sources.
Keratec is a subsidiary of Wool Equities Limited, registered on the New Zealand Stock Exchange under the code NZX: WEL.
For more information, call +64 3 325 6687, email keratec@keratec.co.nz or visit the company's web site at www.keratec.co.nz.
- ends-
For further information, in the U.S. please contact:
Kay Paumier
Communications Plus
510-656-8512
kay@communicationsplus.net
Outside the U.S., please contact:
Christine Moore
Flourish Communication Limited
+64-3-963-3737
christine@flourishcommunication.co.nz |